Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Philips Launches Innovative 3D Navigation System to Enhance Minimally Invasive Treatment of Vascular Disease


News provided by

Royal Philips

29 Apr, 2015, 07:00 GMT

Share this article

Share toX

Share this article

Share toX

This image opens in the lightbox
Philips VesselNavigator - close up display Hybrid Suite (PRNewsFoto/Royal Philips)
This image opens in the lightbox
Prof dr Frank Vermassen at work in Philips Hybrid Suite with VesselNavigator at the university hospital Ghent Belgium - aneurysma procedure (EVAR) taking place (PRNewsFoto/Royal Philips)
This image opens in the lightbox
Prof dr Frank Vermassen at work in Philips Hybrid Suite with VesselNavigator at the university hospital Ghent Belgium - aneurysma procedure (EVAR) taking place - 2 (PRNewsFoto/Royal Philips)
This image opens in the lightbox
Professor dr Frank Vermassen from University Hospital Ghent during planning phase (PRNewsFoto/Royal Philips)
This image opens in the lightbox
VesselNavigator navigation image (PRNewsFoto/Royal Philips)

AMSTERDAM, April 29, 2015 /PRNewswire/ --

  • VesselNavigator has been designed for use in conjunction with Philips interventional X-ray systems to guide catheters during treatment of vascular disease
  • Major reduction of contrast medium (70%) demonstrated in clinical study, enabling minimally invasive treatment of aortic aneurysms in the fast growing number of patients currently unable to benefit from minimally-invasive techniques

Royal Philips (NYSE: PHG, AEX: PHIA) today announced the launch of VesselNavigator*, its latest innovation in live 3D catheter navigation to guide the minimally invasive treatment of patients with vascular diseases such as aortic aneurysms (ballooning of the aorta). This new catheter navigation solution, designed for use in conjunction with Philips' interventional X-ray systems, enhances the precision and accuracy of stent placement, while at the same time significantly reducing contrast medium usage. As a result, minimally invasive treatment options will be available to patients previously unable to benefit from new image-guided intervention techniques.

     (Photo: http://photos.prnewswire.com/prnh/20150429/740664-a )

     (Photo: http://photos.prnewswire.com/prnh/20150429/740664-b )

     (Photo: http://photos.prnewswire.com/prnh/20150429/740664-c )

     (Photo: http://photos.prnewswire.com/prnh/20150429/740664-d )

     (Photo: http://photos.prnewswire.com/prnh/20150429/740664-e )

Developed in collaboration with clinical partners such as the University Hospital Cologne (Germany) and the University Hospital Ghent (Belgium), VesselNavigator complements Philips' current image-guided therapy portfolio within the field of endovascular and hybrid suite solutions. It addresses the need for advanced 3D live-image guidance solutions, as the treatment for vascular disease is experiencing a major transition from open surgery to minimally invasive procedures, with such procedure volumes growing at high single-digit rates.

During endovascular procedures a catheter is maneuvered, with the aid of image guidance, through major arteries or veins in order to locally position and deploy implants such as stents to reinforce the wall of the affected blood vessel. Using conventional 2D X-ray image guidance, clinicians often perceive the visualization of the vessel anatomy during these procedures as if a dimension is missing, adding to procedure complexity. Many are more familiar with open surgery, during which they can physically see and touch the blood vessels they are trying to repair. VesselNavigator brings back the 3D anatomy they were used to seeing in open surgery.

VesselNavigator can be used for all types of endovascular procedures, but one of its key applications is guidance during the treatment of aortic aneurysms, which if left untreated could lead to severe complications such as massive internal bleeding. At the location of the aneurysm, the aorta often has smaller side branches, such as those that supply blood to the patient's kidneys. Custom-made stents are therefore often made with dedicated openings that need to be precisely registered with these feeding vessels in order to repair the aorta and maintain critical blood flow to other abdominal organs. With conventional X-ray imaging it is very challenging to position the stent in the precise orientation. Endovascular aortic aneurysm repair is therefore a very complex procedure, and the more time it takes, the more contrast medium is needed for X-ray visualization and guidance in order to succeed.

VesselNavigator fuses live interventional X-ray images with pre-acquired 3D MRI or CT images of the patient's vascular structures. The resulting 3D color-coded images of the vessels provide enhanced real-time visual guidance, making it easier to maneuver through the vascular network without the need to enhance the X-ray visualization with the repeated use of an injected contrast medium. In recent studies, VesselNavigator has been shown to reduce contrast medium usage by 70% [1] and procedure times by 18%[2] , contributing to more patient friendly, more efficient and more cost effective treatment of vascular conditions.

"VesselNavigator gives vascular surgeons during endovascular procedures the 3D view of the patient's anatomy, which they are familiar with from open surgery. It also significantly reduces the amount of contrast medium required, which means a lesser burden on the kidneys. And with a growing population of elderly and diabetic people who suffer from poor kidney function, reducing contrast medium requirements will open up endovascular treatments to a wider range of patients," says Professor Dr. Frank Vermassen, Head of Vascular and Thoracic Surgery at University Hospital Ghent.

"The strong growth in image-guided therapy procedures is driven by the significant benefits they offer for healthcare systems and patients, including reduced patient trauma, shorter hospital stays, and lower health care costs," said Bert van Meurs, General Manager Image Guided Therapy at Philips. "It is an area where technology innovation and clinical innovation go hand in hand. VesselNavigator shows our commitment to - in close collaboration with leading clinical and industrial partners - advance the development of innovative technologies that enable less invasive, more accurate and localized therapies."

VesselNavigator joins Philips' extensive portfolio of live, 3D image-guided navigation solutions for image-guided minimally invasive therapies. This portfolio also includes HeartNavigator and EchoNavigator for structural heart disease repairs, EP Navigator for cardiac electrophysiology interventions, and EmboGuide to support tumor embolization in cancer treatment. Philips' leading position in image-guided therapies was recently further enhanced by the acquisition of Volcano Corporation, a global leader in catheter-based imaging and measurement solutions for cardiovascular applications.


* Not available for sale in the U.S. - pending 510(k) clearance

About Royal Philips  

Royal Philips (NYSE: PHG, AEX: PHIA) is a diversified health and well-being company, focused on improving people's lives through meaningful innovation in the areas of Healthcare, Consumer Lifestyle and Lighting. Headquartered in the Netherlands, Philips posted 2014 sales of EUR 21.4 billion and employs approximately 105,000 employees with sales and services in more than 100 countries. The company is a leader in cardiac care, acute care and home healthcare, energy efficient lighting solutions and new lighting applications, as well as male shaving and grooming and oral healthcare. News from Philips is located at http://www.philips.com/newscenter.

--------------------------------------------------

1. Ref Pubmed: Tacher et al; J Vasc Interv Radiol. 2013 Nov;24(11):1698-706

2. Ref Pubmed: Sailer et al; Eur J Vasc Endovasc Surg. 2014 Apr;47(4):349-56

For further information, please contact:

Steve Klink
Group Communications
Tel.: +31-6-10-8888-24
E-mail: steve.klink@philips.com

Joost Maltha
Philips Healthcare Benelux
Tel.: +31-6-10-55-8116
E-mail: joost.maltha@philips.com

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.